Annovis Bio to Present Data at Alzheimer's Association International Conference 2021 Highlighting Positive Clinical Outcomes from Its Two Phase 2a TrialsNewsfile Corp • 07/02/21
Annovis Bio CEO Wins 2021 PACT Enterprise Award for Life Sciences and Healthcare CEONewsfile Corp • 07/01/21
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's InvestmentsThe Motley Fool • 06/11/21
Annovis Bio Expands Potential Application of ANVS401 to Infectious Diseases with New Preclinical StudyNewsfile Corp • 06/08/21
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising InvestmentSeeking Alpha • 06/02/21
Annovis Bio's ANVS401 Improves Speed and Accuracy in Alzheimer's and in Parkinson's PatientsNewsfile Corp • 06/01/21
Annovis Bio Engages Global Executive Search Leader Spencer Stuart to Expand its Board and Management TeamNewsfile Corp • 05/28/21
Annovis Bio: Positive Phase 2 Alzheimer's Cognition Data Strengthens Bullish ThesisSeeking Alpha • 05/23/21